Author:
Heeringa M. J.,d'Agostini F.,DeBoer P.,DaPrada M.,Damsma G.
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference55 articles.
1. Acquas E, Carboni E, de Ree RHA, Da Prada M, Di Chiara G (1992) Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592. J Neurochem 59(1): 326?330
2. Barbeau A (1981) The use of L-DOPA in Parkinson's disease: a 20 year follow-up. Trends Pharmacol Sci 2: 297?299
3. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological, and neurochemical correlation's. J Neurol Sci 21: 297?301
4. Birkmayer W, Riederer P, Youdim MBH, Linnauer W (1975) The potentiation of the akinetic effect after L-DOPA treatment by an inhibitor a MAO-B, deprenyl. J Neural Transm 36: 303?326
5. Borgulya J, Bruderer H, Bernauer K, Z�rcher G, Da Prada M (1989) Catechol-O-methyltransferease-inhibiting pyrocatechol deratives: synthesis and structure-activity studies. Helv Chim Acta 72: 952?968
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献